[Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
D001794:Blood Pressure / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007267:Injections; D007511:Ischemia / Q000150:complications / Q000188:drug therapy; D005996:Nitroglycerin / Q000494:pharmacology / Q000627:therapeutic use*; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000494:pharmacology; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D009599:Nitroprusside; D005996:Nitroglycerin; D010646:Phentolamine
Place de la trinitrine injectable ar rapport aux autres vasodilatateurs dans le traitement de l'insuffisance cardiaque d'origine ischémique.